205 related articles for article (PubMed ID: 1732665)
1. Morphologic classification of the myelodysplastic syndromes (MDS): combined utilization of bone marrow aspirates and trephine biopsies.
Bartl R; Frisch B; Baumgart R
Leuk Res; 1992; 16(1):15-33. PubMed ID: 1732665
[TBL] [Abstract][Full Text] [Related]
2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
3. Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.
Drexler B; Tzankov A; Martinez M; Baerlocher S; Passweg JR; Dirnhofer S; Tsakiris DA; Dirks J
Int J Lab Hematol; 2021 Oct; 43(5):1078-1084. PubMed ID: 33709561
[TBL] [Abstract][Full Text] [Related]
4. Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsy.
Delacrétaz F; Schmidt PM; Piguet D; Bachmann F; Costa J
Am J Clin Pathol; 1987 Feb; 87(2):180-6. PubMed ID: 3812349
[TBL] [Abstract][Full Text] [Related]
5. Topics in bone marrow biopsy pathology: role of marrow topography in myelodysplastic syndromes and evaluation of post-treatment and post-bone marrow transplant biopsies.
Reddy VV
Ann Diagn Pathol; 2001 Apr; 5(2):110-20. PubMed ID: 11294998
[TBL] [Abstract][Full Text] [Related]
6. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis.
Maschek H; Kaloutsi V; Rodriguez-Kaiser M; Werner M; Choritz H; Mainzer K; Dietzfelbinger M; Georgii A
Ann Hematol; 1993 Mar; 66(3):117-22. PubMed ID: 8471656
[TBL] [Abstract][Full Text] [Related]
7. Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma: institutional experience and literature review.
Moid F; DePalma L
Arch Pathol Lab Med; 2005 Apr; 129(4):497-501. PubMed ID: 15794673
[TBL] [Abstract][Full Text] [Related]
8. Cytologic evaluation of Papanicolaou-stained bone marrow aspirates.
Berman JJ; McNeill RE
Diagn Cytopathol; 1989; 5(4):383-7. PubMed ID: 2482155
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
10. [Histopathology and clinical aspects of primary myelodysplastic syndrome].
Maschek H; Georgii A
Pathologe; 1995 Jan; 16(1):53-61. PubMed ID: 7886015
[TBL] [Abstract][Full Text] [Related]
11. Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies.
Franklin IM; Pritchard J
J Clin Pathol; 1983 Nov; 36(11):1215-8. PubMed ID: 6630571
[TBL] [Abstract][Full Text] [Related]
12. Trephine biopsy of the bone marrow in disseminated histoplasmosis.
Davies SF; McKenna RW; Sarosi GA
Am J Med; 1979 Oct; 67(4):617-22. PubMed ID: 495631
[TBL] [Abstract][Full Text] [Related]
13. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.
Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R
Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears.
Tricot G; De Wolf-Peeters C; Hendrickx B; Verwilghen RL
Br J Haematol; 1984 Jul; 57(3):423-30. PubMed ID: 6589011
[TBL] [Abstract][Full Text] [Related]
15. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
[TBL] [Abstract][Full Text] [Related]
16. Hypocellular myelodysplastic syndromes: clinical and biological significance.
Marisavljevic D; Cemerikic V; Rolovic Z; Boskovic D; Colovic M
Med Oncol; 2005; 22(2):169-75. PubMed ID: 15965280
[TBL] [Abstract][Full Text] [Related]
17. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization reveals closely correlated results in cytological and histological specimens of hematological neoplasias compared to conventional cytogenetics.
Gerr H; Gadzicki D; Kreipe H; Schlegelberger B; Wilkens L
Pathobiology; 2006; 73(6):271-9. PubMed ID: 17374964
[TBL] [Abstract][Full Text] [Related]
19. [Myelosclerosis in myelodysplastic syndromes (MDS). Retrospective analysis of 232 patients with MDS].
Maschek H; Kaloutsi V; Werner M; Bandecar K; Buhr T; Georgii A
Verh Dtsch Ges Pathol; 1990; 74():144-8. PubMed ID: 1708573
[TBL] [Abstract][Full Text] [Related]
20. [Survey on examinations for diagnosis of bone marrow failure in Japan: a report from the Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes].
Araseki K; Matsuda A; Tohyama K; Ishikawa T; Kawabata H; Miyazaki Y; Nakao S; Tomonaga M; Takaori-Kondo A; Kurokawa M; Omine M; Ozawa K
Rinsho Ketsueki; 2012 Jul; 53(7):691-7. PubMed ID: 22975771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
